Save time and jump to the most important pieces.
4 - Syra Health Corp (0001922335) (Issuer)
EFFECT - Syra Health Corp (0001922335) (Filer)
S-3/A - Syra Health Corp (0001922335) (Filer)
S-3 - Syra Health Corp (0001922335) (Filer)
4 - Syra Health Corp (0001922335) (Issuer)
4 - Syra Health Corp (0001922335) (Issuer)
4 - Syra Health Corp (0001922335) (Issuer)
CARMEL, Ind., Feb. 13, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), a healthcare technology company powering better health by providing meaningful solutions, announced today that it has been awarded a six-month, $135,000 contract with a Midwest-based university to develop prevention-focused virtual training modules in behavioral health. Syra Health will collaborate with the university, its advisory committees, and subject matter experts to develop and implement the behavioral health training modules. The content will equip professionals with the skills necessary to ad
CARMEL, Ind., Jan. 7, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that the Washington D.C. government has awarded it a healthcare workforce contract, valued at up to $1 million, on behalf of the Office of the State Superintendent of Education. The Company also announced that the Indiana Family and Social Services Administration's NeuroDiagnostic Institute has increased its existing contract by $1.2 million, bringing the total value to $18.7 million.
- Now Available for Download on the App Store and Google Play Store. CARMEL, Ind., Dec. 2, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that its flagship mental health app, Syrenity, is now available for direct download by adults 18 years and older. Syrenity leverages a science-driven approach to address prevalent mental health challenges such as stress, anxiety, and depression, positioning the Company to capture growth opportuniti
Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year Quarter Gross Margins Increased Following Shift in Operational Strategy Net Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the $1.39 million ($0.21 per share) Net Loss in Q2 of 2024 Aiming to Attain Profitability in 2025 through Targeted Revenue Growth and Cost-Efficiency Measures Conference call will be held today, Tuesday, October 29th at 9:00 AM ET CARMEL, Ind., Oct. 29, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company driving better health through impactful, innovative solutions, announced today its financial results for
In the news release, Syra Health To Discuss Third Quarter 2024 Financial Results, issued 22-Oct-2024 by Syra Health over PR Newswire, we are advised by the company that the webcast link listed in the second and fourth paragraphs was incorrect. The URL should read "https://syrahealth.com/ir/presentations/q3-2024-earnings-call" rather than "https://dev.syrahealth.com/ir/presentations/q3-2024-earnings-call" as originally issued inadvertently. The complete, corrected release follows: Syra Health To Discuss Third Quarter 2024 Financial Results Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra He
Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended September 30, 2024, on Tuesday, October 29, 2024, before the market opens. The Company has scheduled a conference call that same day, October 29, at 9:00 a.m. ET, to review the results. Interested parties can access the conference call
SC 13G - Syra Health Corp (0001922335) (Subject)